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1.  Linear optical spectra of the compounds 
 
Figure S1. Linear optical spectra of the porphyrin compounds, related to Figure 2: 
Comparison of absorption and emission spectra (in DMF at 25 °C) of cationic charged dyes AK-1, JR-2, 
JF-1, AK-1.Cu and neutral dyes, JW-1, IG-1, and JF-2.  
 
2.  Cell imaging 
 
Figure S2. Imaging of non-charged dyes JW-1 and IG-1 in HEK 293T cells, related to 
Figure 3: The fluorescence images of the dyes, JW-1 and IG-1 in the cells show no localization in the 
plasma membrane. No SHG was seen from the intracellular area. Scale = 20 µm (JW-1), 10 µm (IG-1).  
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Figure S3. Imaging of JR-2 in HEK 293T cells, related to Figure 3: The fluorescence and 
SHG JR-2 in HEK 293T cells. The dyes could be seen staining the intracellular organelles of the cells to 
give both fluorescence and SHG signals. λext = 840 nm, scale bar = 10 µm.  
 
 
Figure S4. Co-localization of JR-2 with ER Tracker in HEK 293T cells, related to Figure 
3: The SHG image is from only JR-2, while the fluorescence image is from only ER-Tracker™ Red dye 
detected in the red channel (570–625 nm). Fluorescence + SHG shows the co-localization of JR-2 with 
ER-Tracker™ Red dye. Scale bar = 20 µm.  
 
 
The co-localization experiment (Figure S4) shows that SHG is generated from JR-2 dye molecules 
staining the intracellular organelles including endoplasmic reticulum. Although the porphyrin dye also 
emits fluorescence, it is not detected because the light was passed through a 570–625 nm filter (the dye 
does not emit in this range) before being detected through the PMT.  
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Figure S5. Imaging of JF-1 in LN-18 cells, related to Figure 3: Fluorescence and SHG images 
of JF-1 (10 µM) in LN-18 cells. λext = 840 nm, scale bar = 20 µm.  
  
 
Figure S6. Fluorescence imaging of FM4-64 in mouse brain sl ice, related to Figure 4: 3D 
image of a section of mouse brain slice stained with FM4-64 (50 µM) without Advasep. The dye could 
be seen absorbed all over the area staining the neural tissue and cells alike. Scale bar = 20 µm.  
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Figure S7. SHG imaging of only SHG dye, JF-1.Cu, related to Figure 6: Images of JF-1.Cu 
(40 µM) incubated in LN-18 cells. The LN-18 cells were cultured and maintained following the same 
protocol as HEK 293T cells. The dye does not emit any fluorescence but generates strong SHG signals 
from the plasma membrane. The overlay of fluorescence and SHG images show that no yellow color (if 
red and green are mixed) is generated. λext = 850 nm, scale bar = 20 µm.  
 
 
 
Figure S8. Imaging of FM4-64 and Di-4-ANEPPS as control experiments, related to 
Figure 7: Dicationic and zwitterionic dyes, FM4-64 (10 µM) and di-4-ANEPPS (10 µM) incubated in 
with the HEK 293T cells. The images were taken immediately after the dye incubation. FM4-64 does 
not get internalized in the cells just after incubation as minimal fluorescence is visible from the 
intracellular area. Di-4-ANEPPS is internalized by the cells apart from staining the plasma membrane. 
Significant fluorescence is seen from inside the cells stained with di-4-ANEPPS apart from bright SHG 
from the plasma membrane. λext = 840 nm, scale bar = 20 µm.   
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 Transparent Methods 
 
1.  Linear optical properties of the porphyrin-based dyes 
The UV-Vis (Perkin Elmer Lambda 20) and fluorescence (Edinburgh Instruments, Spectrofluorometer 
FS5) measurements were performed in DMF at 25 °C. 
Measurement of f luorescence quantum yields  
The quantum yield of a compound is given by the equation: 𝜙! = 𝜙!  𝐼!𝐴! 𝑛!𝐼!𝐴! 𝑛!"#! 
where φC is the quantum yield of the compound, φR is the quantum yield of the reference compound, Ic is 
the fluorescence intensity of the compound, IR is the fluorescence intensity of the reference compound, 
Ac is the absorbance of the compound (<0.1), AR is the absorbance of the reference (<0.1), n is the 
refractive index of the solvent (DMF = 1.4305) in which the compound of interest is dissolved and nref 
(CH2Cl2 = 1.4244) is the refractive index of the solvent in which the reference is dissolved. The 
absorbance values, Ac and AR were measured at the same wavelengths at which the emission of the 
compounds was measured. To quantify the fluorescence intensities, Ic and IR, the emission spectra of the 
compounds were integrated over the whole region. The reference was analyzed in CH2Cl2 while the 
unknown compound was analyzed in DMF. The quantum yields of the dyes were calculated by 
measuring their absorbances and fluorescence intensities and then comparing them with the 
absorbance and fluorescence intensity of the reference compound, pyropheophorbide-a methyl ester 
according to the above equation. For each compound, five measurements were done at different 
absorbances (<0.1). The reported quantum yield of pyropheophorbide-a methyl ester (φ = 0.22 in 
CH2Cl2) was used as a reference (Sasaki et al., 2010).  
 
2.  Cell Imaging 
Culturing HEK 293T cells: A stock of human embryonic kidney (HEK) 293T cells was procured from 
ATCC (American Type Culture Collection) company. All the media and supplements were procured 
from Sigma Aldrich unless otherwise specified. The cells were suspended in 10 mL of phenol red free 
DMEM media (FluoroBrite™ from ThermoFisher Scientific) containing 4.5 g/L glucose, supplemented 
with 10% fetal bovine serum (FBS), 2 mM L-glutamine and 1 mM sodium pyruvate. The cell suspension 
was centrifuged at 200 G for 10 minutes to pellet the cells. The supernatant was discarded, and the cell 
pellet was suspended in 5 mL of phenol-red free supplemented DMEM media and then mixed with 10 
mL of the media in a T75 flask and incubated at 37 °C in 5% CO2 for 48 h. After 48 h, 1/10th of the cells 
were passaged to a new T75 flask with 15 mL of fresh phenol red free supplemented DMEM media to 
be incubated at 37 °C in a CO2 incubator until they are 70% confluent. After the cells became 70% 
confluent, they were further passaged into six T75 flasks (1/6th of cells in each flask) until they are 70% 
confluent. Stock solutions were prepared from the six T75 flasks of 1 mL each at a density of 1 million 
cells/mL in 10% DMSO, 20% FBS supplemented DMEM media (phenol red free) and frozen at −80 °C 
using Mr. Frosty™ cell freezer.  
The cells grown in a T25 or T75 flask were washed with Ca2+ and Mg2+ free Hank’s balance salt 
solution (HBSS) buffer after decanting the media. The cells were then re-suspended in 5 mL of 
supplemented media. The cell suspension (500 μL) was then mixed with 6 mL of media in a T25 flask 
and incubated at 37 °C in a CO2 incubator until they are about 70% confluent.  
  
Incubation of dye: The cells were plated in poly-D-lysine coated 50 mm glass-bottom dishes 
(MatTek®) at 37 °C in a CO2 incubator to 70% confluency. When the cells were confluent, they were 
washed with Ca2+ and Mg2+ free HBSS buffer and incubated with the desired concentration of dye in 
0.1% to 0.5% DMSO in HBSS buffer (with Ca2+ and Mg2+ ions). For co-localization and control 
experiments, FM4-64 was procured from Biotium under the name SynaptoRed C2. LysoTracker™ 
Yellow HCK-123, rhodamine 123 (RH123), di-4-ANEPPS, and ER-Tracker™ Red (BODIPY™ TR 
Glibenclamide) were procured from ThermoFisher Scientific. 
 
Cultured rat hippocampal neurons: Cultured primary rat hippocampal neurons were a kind gift 
from Prof. Nigel Emptage, Department of Pharmacology at the University of Oxford. All reagents were 
procured from Invitrogen unless otherwise stated. Hippocampi were dissected from E18 Wistar rat 
embryos (Charles River Laboratory), dissociated in 0.5 mg/mL trypsin in HBSS for 15 minutes at 37 °C, 
washed twice in culture medium and gently triturated in culture medium using a briefly fire polished 
P1000 plastic pipette tip. Dissociated neurons were plated at a density of ~250/mm2 on poly-D-lysine 
coated 50 mm glass bottom dishes from MatTek®. After attachment, neurons were incubated in 
Neurobasal medium supplemented with 2% fetal calf serum (FCS), 2% B27, 1% Glutamax and 1% 
penicillin/streptomycin. The day after plating, half the medium was changed for Neurobasal 
supplemented with 2% B27 and 1% Glutamax only; this medium was used for all further feeds. Cultures 
were maintained in an incubator at 37 °C perfused with 5% CO2. Cultures were used for experiments at 
14–21 days in vitro when synapses are mature. All animal work was carried out in accordance with the 
Animals (Scientific Procedures) Act, 1986 (UK). 
 
Mice brain sl ices: Postnatal day (P) 14-21 C57BL/6 mice of both sexes were anaesthetized by 
isoflurane inhalation. The animals were decapitated in accordance with British Home Office regulations. 
The brain was removed swiftly and stored in ice-cold (0–4 °C) artificial cerebrospinal fluid (NaCl 126 
mM, KCl 3 mM, NaH2PO4 1.25 mM, MgSO4 2 mM, CaCl2 2 mM, NaHCO3 26 mM, and glucose 10 mM; 
pH 7.2–7.4; osmolarity 285–300 mOsm L–1) for approx. 10 min (aCSF). aCSF was continuously bubbled 
with carbogen gas (95% O2 and 5% CO2) for at least 30 min before use. A thin section of dorsal surface 
was cut with a scalpel after separating the hemispheres. The dorsal part of the hemisphere was glued to 
a microtome pate for cyanoacrylate adhesive. Horizontal slices of entorhinal cortex (300–350 µm thick) 
were cut with a vibrotome (Leica VT 1000s) in aCSF. 
 For imaging experiments, the slices were stored in aCSF and bubbled continuously with 
carbogen using a perfusion setup. For pressure injection delivery, the dye was dissolved in HBSS buffer 
solution using 0.1% DMSO and delivered using a pulled patch-clamp–based pipette from Harvard 
Instruments.  
 
Microscope: The imaging experiments were performed using an Olympus FV1200MPE-BX61WI 
microscope equipped with Mai Tai® eHP DeepSee™ Ti:Sapphire laser (70 fs pulse width, 80 MHz 
repetition rate, continuously tunable between 690–1040 nm) from Spectra-Physics. The light was 
focused using a 2 mm working distance 25X multiphoton objective (XLPLN25XWMP2). For TPEF, the 
reflected light was passed through a 750 nm short pass filter before being passed through a 540 nm 
long pass (LP) filter or a dichroic mirror separating the light to pass through green (495–540 nm) and red 
(570–625 nm) band pass filters and then was detected by PMT detectors (Hamamatsu R3896 for green 
 and Hamamatsu IR sensitive PMT-R10699 for red). For SHG, the light in the transmitted direction was 
collected through a 0.9 NA air-based condenser and then passed through a band-pass filter (405–435 
nm) before being detected through a PMT detector (Hamamatsu R3896). All the images were acquired 
in analog-integration mode unless otherwise specified. The images were processed using Olympus 
Fluoview software and Imaris x64 7.7 software. The images presented here are scanned with a pixel 
dwell time of 2–12.5 µs/pixel at 512 × 512 pixels.  
All the images are taken at 870 nm at ≤5 mW laser power unless otherwise specified. The 
concentration of the dyes are, AK-1 = 20 µM (HEK 293T cells), 40 µM (cultured neurons), 25 µM (rat 
brain slices), JF-1 = 10 µM, AK1.Cu = 20 µM, JF-2 = 10 µM (840 nm), JR-2 = 5 µM (840 nm), JR-3 = 
10 µM (840 nm), JW-1 = 20 µM, IG-1 = 20 µM, FM4-64 = 20 µM (multimodal imaging), FM4-64 = 10 
µM (for comparison with di-4-ANEPPS, 840 nm), di-4-ANEPPS = 10 µM (840 nm), RH123 = 20 µM, 
LysoTracker™ Yellow HCK-123 = 3 µM, and the ER-Tracker™ Red = 5 µM.  
 
3.  Supplemental synthetic procedures  
 
General synthetic procedure: All commercial reagents and solvents were procured from Sigma 
Aldrich unless specified. The chloroform, dimethylformamide, pyridine, tetrahydrofuran, and 
dimethylsulfoxide were procured from Fisher Scientific, and dichloromethane was procured from 
Honeywell Riedel-de-Haën. Deuterated solvents were procured from Aldrich. The SX-1 resins for size-
exclusion chromatography was procured from Bio-Beads® and the Dowex® chloride anion exchange 
resin were procured from Sigma Aldrich. The Geduran® Si 60 silica gel was used for flash column 
chromatography. Benchtop centrifuge from Eppendorf was used to wash the final compound AK-1 
with solvents during its purification. Compounds 1, 2, JR-2 and JR-3 were synthesized as per our 
previously reported literature procedure (Lopez-Duarte et al., 2013; Reeve et al., 2009). 
Chemical reactions were performed under inert atmosphere (Ar gas) unless otherwise stated. 
NMR spectra were acquired on 400 MHz (Bruker AVIIIHD 400) and 500 MHz (Bruker AVII 500, Bruker 
AVIIIHD 500) spectrometers. Chemical shifts are reported in ppm relative to tetramethylsilane (TMS) as 
internal standard. MALDI-ToF (Waters MALDI micro) spectrometer was used for mass analysis.  
 
 
 
 3.1 Synthesis of JF-2 and JF-3 
 
 
Scheme S1. Synthetic procedure for JF-1 and JF-2, related to Figure 1. In the last step, 1-iodo-5-
triethylammonium-pentane was used as the alkylating agent to synthesize JF-1, while 1,4-butane 
sultone was used to synthesize JF-2.  
 
Compound 12 was synthesized according to the literature procedure (Tykwinski et al., 1996).   
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 Compound 5: Dipyrromethane was synthesized as per literature procedure (Littler et al., 
1999). Briefly, formaldehyde (33% w/w solution in water, 10.8 mL, 120 mmol) was added to 
pyrrole (200 mL, 2.88 mol) and the solution degassed by repeated evacuation and stirring 
under Ar at RT. Trifluoroacetic acid (1.08 mL, 14.1 mmol) was added by syringe under 
vigorous stirring and in the Ar atmosphere. The reaction proceeded for 5 min before CH2Cl2 
(200 mL) was added, followed immediately by Na2CO3 (aq., sat., 200 mL). The organic layer 
was washed with Na2CO3 (aq.) (sat., 2 × 200 mL) and water (2 × 200 mL), then dried over Na2SO4. The 
solvent and then excess pyrrole were evaporated under reduced pressure. Distillation of the oily residue 
in a Kugelrohr apparatus (180 ºC, 0.6 mbar) yielded the product 5 as a white solid. The product 
solidifies in the collecting vial into a robust stone difficult to remove. The convenient way to collect it is 
by washing with CH2Cl2. Yield: 6.9 g, 40%. 1H NMR (400 MHz, CDCl3) δ/ppm: 7.76 (br s, 2 H, NH), 
6.64 (m, 2 H, pyrrole α-H), 6.16 (m, 2 H, pyrrole β-H), 6.04 (m, 2 H, pyrrole β-H), 3.96 (s, 2 H, CH2). 13C 
NMR (100 MHz, CDCl3) δ/ppm: 121.2, 117.4, 108.4, 106.5, 26.4.  
 
Porphyrin 7: This compound was prepared by adapting a literature procedure 
(Balaz et al., 2009). Dipyrromethane 5 (2.34 g, 16.0 mmol) and 3-(2-[2-(2-methoxy-
ethoxy)-ethoxy]-ethoxy)-benzaldehyde 6 (4.30 g, 16.0 mmol) were dissolved in DCM 
(2.4 L). The solution was stirred vigorously and degassed by bubbling with N2 for 0.5 
h and trifluoroacetic acid (1.2 mL) was added via syringe under gentle bubbling of 
N2. The flask was shielded from light with and the solution stirred at room 
temperature for 3.5 h. 2,3-Dichloro-5,6-dicyano-1,4-benzoquinone (DDQ, 4.40 g, 
19.4 mmol) was added and the solution stirred for a further 30 min. The mixture was 
neutralized with triethylamine (25 mL), the crude mixture was concentrated to 500 
mL and then poured directly onto a silica gel pad (50 cm × 4 cm) packed in DCM. Fast-running DDQ 
residues were removed with DCM and the product eluted with 99:1 DCM:MeOH. A second flash 
chromatography of increasing polarity (SiO2; DCM:EtOAc 9:1 to 5:1 to 3:1) was performed to ensure 
that all tarry residues and side products were removed. On removal of the solvent and drying under 
high vacuum, product 7 was obtained as a purple solid glass. Yield: 2.0 g, 30 %. 1H NMR (500 MHz, 
CDCl3/1% pyridine) δ/ppm: –3.09 (br. s, 2H, NH), 3.30–3.35 (m, 6H, OCH3), 3.46–3.52 (m, 4H, OCH2), 
3.60–3.65 (m, 4H, OCH2), 3.66–3.71 (m, 4H, OCH2), 3.74–3.80 (m, 4H, OCH2), 3.89–3.97 (m, 4H, OCH2), 
4.30–4.37 (m, 4H, OCH2), 7.36–7.41 (m, 2H, CH), 7.66–7.72 (m, 2H, CH), 7.85–7.90 (m, 4H, CH), 9.12–
9.15 (m, 4H, CH), 9.37 (d, J = 4.5 Hz, 4H, CH), 10.27–10.31 (m, 2H, CH). 13C NMR (125 MHz, CDCl3/ 1% 
pyridine-d5) δ/ppm: 59.0 (OCH3), 67.7, 69.8, 70.5, 70.6, 70.9, 71.9 (OCH2), 105.3, 114.2, 118.8, 121.4, 
127.7, 128.0, 131.1, 131.6, 142.6, 145.2, 147.0, 157.5 (CHAr, CAr). m/z (MALDI-TOF): 786.59 
(C46H50N4O8, [M]+, requires 786.36, 100%); m/z (HRMS, MICRO-TOF): 809.3522 (C46H50N4NaO8, 
[M+Na]+, requires 809.3521). 
 
Porphyrin 8: This compound was prepared by adapting literature procedure (Balaz et al., 2009). 
Porphyrin 7 (1.0 g, 1.27 mmol) was dissolved in chloroform (100 mL) with pyridine 
(0.7 mL). A solution of NBS (2.1 eq., 480 mg, 2.7 mmol) in chloroform (50 mL) and 
pyridine (0.4 mL) was added dropwise over 60 min. The mixture was stirred for 1 h 
and the progress was monitored by TLC (SiO2; DCM:EtOAc 3:1 or DCM:acetone 
20:1). After quenching with acetone (5 mL), the solvents were removed under 
reduced pressure; the crude material was dissolved in toluene and extracted three 
to four times with water to remove the N-hydroxysuccinimide. After the product 8 
was eluted from a silica column with (SiO2; DCM: EtOAc 3:1) and evaporation of 
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 the solvent, porphyrin 8 was obtained in form of a purple viscous oil. Yield: 1.21 g, 95–99 %. 1H NMR 
(500 MHz, CDCl3/ 1% pyridine-d5) δ/ppm: –2.76 (br. s, 2H), 3.32 (s, 6H), 3.47–3.51 (m, 4H), 3.60–3.64 (m, 
4H), 3.67–3.71 (m, 4H), 3.76–3.80 (m, 4H), 3.93–3.98 (m, 4H), 4.30–4.39 (m, 4H), 7.35–7.41 (m, 2H), 
7.61–7.69 (m, 2H), 7.72–7.78 (m, 4H), 8.82–8.95 (m, 4H, J = 4.4 Hz), 9.59 (d, 4H, J = 4.8 Hz). 13C NMR 
(125 MHz, CDCl3/ 1% pyridine-d5) δ/ppm: 59.0 (OCH3), 67.7, 69.8, 70.5, 70.6, 70.9, 71.9 (OCH2), 103.7, 
114.4, 121.0, 121.2, 127.6, 127.7, 132.4, 142.5, 157.2 (CHAr, CAr). m/z (MALDI-TOF): 944.95 
(C46H48Br2N4O8, [M]+, requires 944.18, 100%); m/z (HRMS, MICRO-TOF): 965.1728 
(C46H48Br2N4NaO8, [M+Na]+, requires 965.1731). 
 
Compound 9: Chlorotrihexylsilane (15.2 mL, 41.6 mmol) was added 
dropwise under Ar to a stirred solution of ethynylmagnesium bromide (0. 50 
M in THF, 100 mL, 50.0 mmol). The reaction mixture was heated at reflux for 1 h before HCl (aq.) (10%, 
80 mL) was added. The organic layer was washed with water (80 mL) and dried over Na2SO4. The 
product was dried at a reduced pressure of 0.4 mbar for 30 min to yield a yellow oil. Yield: 10.0 g, 
77.9%. 1H NMR (400 MHz, CDCl3) δ/ppm: 2.35 (s, 1 H, ≡CH), 1.41–1.22 (m, 24 H, CH2), 0.89–0.83 (m, 9 
H, CH), 0.63–0.56 (m, 6 H, CH). 13C NMR (100 MHz, CDCl3) δ/ppm: 94.1, 88.5, 33.3, 31.6, 23.9, 22.7, 
14.3, 13.2. m/z  (ESI−)  307.3 (C20H40Si, M requires 308.3). 
 
Porphyrin 10: The dibrominated porphyrin 8 (0.99 g, 1.05 mmol), 
trihexylsilylacetylene 9 (1.0 g, 3.14 mmol), Pd2(dba)3 (30 mg, 0.03 
mmol), triphenylphosphine (60 mg, 0.21 mmol) and copper(I) iodide 
(20 mg, 0.1 mmol) were dried under vacuum in a Schlenk tube and 
flushed with argon. Toluene (20 mL) and triethylamine (10 mL) were 
added by syringe and solution was degassed by three freeze-thaw 
cycles. Once it had returned to room temperature, the mixture was 
stirred for 0.5 h and then heated to 40 °C until no further change 
was observed (ca. 3 h; TLC: DCM:EtOAc; 15:1). After the reaction 
mixture was cooled to room temperature, it was diluted with toluene (100 mL) and added into a 
separating funnel that was filled with 150 mL saturated ammonium chloride solution. The mixture was 
washed several times with water and the solvent was evaporated. A silica column with 15:1 DCM:EtOAc 
as the eluent gave the porphyrin 10 as a purple viscous oil. Yield: 1.32 g, 89%. 1H NMR (500 MHz, 
CDCl3 / 1% pyridine-d5) δ/ppm: –2.12 (br. s, 2H, NH), 0.90–0.98 (m, 18H, CH3), 1.03–1.09 (m, 12H, CH2), 
1.35–1.49 (m, 24H, CH2), 1.55–1.63 (m, 12H, CH2), 1.76–1.85 (m, 12H, CH2), 3.34 (s, 6H, OCH3), 3.49–
3.53 (m, 4H, OCH2), 3.62–3.67 (m, 4H, OCH2), 3.69–3.75 (m, 4H, OCH2), 3.79–3.84 (m, 4H, OCH2), 3.96–
4.02 (m, 4H, OCH2), 4.34–4.40 (m, 4H, OCH2), 7.37–7.43 (m, 2H, CH), 7.69 (t, 4H, J = 7.6 Hz, CH), 7.79–
7.83 (m, 4H, CH), 8.90 (d, 4H, J = 4.6 Hz, CH), 9.66 (d, 4H, J = 4.7 Hz, CH). 13C NMR (125 MHz, CDCl3/ 
1% pyridine-d5) δ/ppm: 13.8, 14.2, 22.7, 24.4, 31.7, 33.3 (CH3, CH2), 59.0 (OCH3), 67.8, 69.9, 70.5, 70.7, 
70.9, 71.9 (OCH2), 101.1, 101.4, 107.9, 114.4, 121.1, 121.4, 127.67, 127.69, 130.7 br., 131.6 br., 142.6, 
157.4 (C≡C, CHAr, CAr). m/z (MALDI-TOF) 1401.54 (C86H127N4O8Si2, [M+H]+, requires 1400.92, 100%); 
m/z (HRMS, MICRO-TOF): 1421.8981 (C86H126N4NaO8Si2, [M+Na]+, requires 1421.9006). 
 
Mono desilylated porphyrin 11: Porphyrin 7 (0.44 g, 0.314 mmol), 
was dissolved in chloroform (100 mL) and a solution of 0.6 eq. of TBAF (0.2 
mL; 1.0 M in THF) was added slowly. The progress was monitored by TLC 
(SiO2: DCM:EtOAc; 10:1; 3:1). Once the mixture showed first indications of 
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 the double deprotected derivative the mixture was quenched with acetic acid (12 µL, 0.2 mmol). After 5 
min, MeOH (10 mL) was added and the mixture was then passed through a short column of SiO2. The 
solvent was evaporated under reduced pressure and the remaining crude mixture was purified by flash 
chromatography on silica, eluting with DCM:EtOAc of increasing polarity (15:1 à 10:1). Hereby the 
unreacted starting material (7, 241 mg, 55% yield) eluted as first, followed from the mono (11, 100 mg, 
28% yield) and double deprotected porphyrin. The alkyne 11 has limited stability under normal 
laboratory conditions, so it is normally prepared and used immediately (without further purification and 
characterization) in the following coupling step, for this reason the product is dried in a Schlenk tube, 
ready for use in the next step. It can be stored overnight as a dry solid at –20 °C. 
 
Donor substituted porphyrin  13: The mono-deprotected 
porphyrin 11 (200 mg, 0.18 mmol), 1-iodo-4-N,N-
dioctylamino-benzene 12 (160 mg, 0.36 mmol), Pd2(dba)3 (4.1 
mg, 9 μmol), triphenylphosphine (10 mg, 36 μmol) and 
copper(I) iodide (4.0 mg, 18 μmol) were dried under vacuum in 
a Schlenk tube and flushed with argon. Toluene (7 mL) and 
triethylamine (4 mL) were added by syringe and solution was 
degassed by three freeze-thaw cycles. Once it had returned to 
room temperature, the mixture was stirred at for 0.5 h and then heated to 40 °C until no further change 
was observed (2–3 h; TLC: DCM:EtOAc; 20:1). After the reaction mixture was cooled to room 
temperature, it was diluted with toluene (100 mL) and added into a separating funnel that was filled 
with 150 mL saturated ammonium chloride solution. The mixture was washed several times with water 
and the solvent was evaporated. A silica column with 20:1 DCM: EtOAc as the eluent gave the 
porphyrin 13 as a green glass. Yield: 208 mg, 81%. 1H NMR (400 MHz, CDCl3 / 1% pyridine-d5) δ/ppm: 
–1.89 (br. s, 2H, NH); 0.87–0.94 (m, 15H; CH3), 0.99–1.05 (m, 6H; CH2), 1.25–1.44 (m, 32H; CH2), 1.51–
1.59 (m, 6H; CH2), 1.64–1.72 (m, 4H; CH2), 1.72–1.80 (m, 6H; CH2), 3.31(s, 6H; OCH3), 3.35–3.41 (m, 4H; 
NCH2), 3.47–3.51 (m, 4H, OCH2), 3.61–3.65 (m, 4H, OCH2), 3.68–3.72 (m, 4H, OCH2), 3.77–3.81 (m, 4H, 
OCH2), 3.95–3.99 (m, 4H, OCH2), 4.32–4.37 (m, 4H, OCH2), 6.79 (d, 2H, J = 8.5 Hz, CH), 7.35–7.39 (m, 
2H, CH), 7.63–7.67 (m, 2H, CH), 7.75–7.79 (m, 4H, CH), 7.86 (d, 2H, J = 8.5 Hz, CH), 8.82 (d, 4H, J = 4.6 
Hz, CH), 9.56 (d, 2H, J = 4.7 Hz, CH), 9.66 (d, 2H, J = 4.6 Hz, CH). 13C NMR (125 MHz, CDCl3/ 1% 
pyridine-d5) δ/ppm: 13.8, 14.1, 14.2, 22.7, 24.3, 27.2, 27.3, 29.3, 29.5, 31.6, 31.8, 33.3 (CH3, CH2), 51.1 
(NCH2), 59.0 (OCH3), 67.7, 69.9, 70.5, 70.6, 70.9, 71.9 (OCH2), 90.2, 100.0, 100.8, 103.7, 108.0, 109.1, 
111.5, 114.4, 121.0, 121.2, 127.61, 127.63, 133.1, 142.7, 148.4, 157.3 (C≡C, CHAr, CAr). m/z (MALDI-
TOF): 1432.70 (C90H125N5O8Si2, [M]+, requires 1432.93, 100%); m/z (HRMS, MICRO-TOF): 
1454.9175 (C90H125N5NaO8Si2, [M+Na]+, requires 1454.9190). 
 
Desilylated porphyrin 14: The porphyrin 13 (160 mg, 0.11 
mmol), was dissolved in chloroform (50 mL) and degassed by gentle 
bubbling with nitrogen for 10 min. To this solution 2 eq. of a 
solution of TBAF (0.22 mL, 1.0 M in THF) was added slowly and the 
progress was monitored by TLC (SiO2: DCM: EtOAc; 20:1; 10:1). 
Once the mixture was completely desilylated it was quenched by 
equimolar amounts of glacial acid and stirred for 5 min MeOH (5 
mL) was added and the mixture was then plugged over SiO2. 
Compound 14 has similar to 11 limited stability under normal laboratory conditions, so it is normally 
prepared and used immediately (without further purification and characterization) in the following 
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 coupling step, for this reason the product is dried in a Schlenk tube, ready for use in the next step. Due 
to a TLC clean cleavage reaction, the theoretical yield was assumed to be 100% (127 mg). It can be 
stored overnight as a dry solid at –20 °C.  
 
Donor acceptor substituted porphyrin 16: The 
desilylated porphyrin 14 (127 mg, 0.11 mmol), 1-iodo-pyidine 
15 (120 mg, 0.58 mmol), Pd2(dba)3 (2.7 mg, 3 μmol), bis-
diphenylphosphino-ferrocene (DPPF) (3.5 mg, 1.5 μmol) and 
copper(I) iodide (2.2 mg, 6 μmol) were dried under vacuum in a 
Schlenk tube and flushed with argon. Toluene (7 mL) and 
diisopropylamine (4 mL) were added by syringe and solution 
was degassed by three freeze-thaw cycles. Once it had returned 
to room temperature, the mixture was stirred at for 0.5 h and 
then heated to 40 °C until no further change was observed (1–2 h; TLC: DCM:MeOH; 20:1). After the 
reaction mixture was cooled to room temperature, it was diluted with toluene (100 mL) and added into 
a separating funnel that was filled with 150 mL saturated ammonium chloride solution. The mixture was 
washed several times with water and the solvent was evaporated. A subsequent chromatography on 
silica (20:1 chloroform:MeOH); BIO-Beads® S-X1 (size-exclusion; 200–400 mesh, toluene:pyridine; 100:1) 
and silica (30:1 chloroform:MeOH) gave 16 as a green glass. Yield: 115 mg, 85%. 1H NMR (500 MHz, 
CDCl3 / 1% pyridine-d5) δ/ppm: –1.81 (br. s, 2H, NH); 0.87–0.94 (m, 6H; CH3), 1.21–1.42 (m, 20H; CH2), 
1.62–1.72 (m, 4H; CH2), 3.30 (s, 6H; OCH3), 3.34–3.40 (m, 4H; NCH2), 3.45–3.50 (m, 4H, OCH2), 3.59–
3.64 (m, 4H, OCH2), 3.67–3.71 (m, 4H, OCH2), 3.76–3.80 (m, 4H, OCH2), 3.93–3.98 (m, 4H, OCH2), 4.32–
4.37 (m, 4H, OCH2), 6.77 (d, 2H, J = 8.6 Hz, CH), 7.34–7.39 (m, 2H, CH), 7.62–7.76 (m, 2H, CH), 7.74–
7.78 (m, 4H, CH), 7.80–7.86 (m, 4H, CH), 8.76–8.82 (m, 4H, CH), 8.85 (d, 2H, J = 4.5 Hz, CH), 9.55 (d, 
2H, J = 4.5 Hz, CH), 9.64 (d, 2H, J = 4.5 Hz, CH). 13C NMR (125 MHz, CDCl3/ 1% pyridine-d5) δ/ppm: 
14.1(CH3), 22.6, 27.1, 27.3, 29.3, 29.5, 31.8 (CH2), 51.0 (NCH2), 58.9 (OCH3), 67.7, 69.8, 70.5, 70.6, 70.9, 
71.8 (OCH2), 90.3, 93.8, 96.8, 97.7, 100.7, 104.7, 108.8, 111.5, 114.4, 121.0, 121.7, 125.3, 127.6, 132.0, 
133.2, 142.5, 148.5, 150.0, 157.3 (C≡C, CHAr, CAr). m/z (MALDI-TOF) 1228.27 (C77H91N6O8, [M+H]+, 
requires 1228.7, 100%); m/z (HRMS, MICRO-TOF): 1249.6880 (C77H90N6NaO8, [M+Na]+, requires 
1249.6712);  
General procedure for the alkylation with 1-iodo-5-triethylammonium-pentane: 
The doubly charged compounds JF-1 and JF-1.Cu were prepared by mixing precursors 16, 16.Cu 
(approx. 50 mg) with and an excess of 1-iodo-5-triethylammonium-pentane (approx. 500 mg) in 2-
pentanone (4 mL). The mixture was heated under argon to 80–90 °C. The reaction progress was 
monitored by TLC (SiO2: chloroform:MeOH; 20:1) and after the most of the starting material was 
consumed (approx. 4 h), the solvent was removed under reduced pressure. Washing the crude mixture 
of JF-1.Cu on a filter paper with water allowed removing the excess of 1-iodo-5-triethylammonium-
pentane, whereas the porphyrin free base JF-1 was dissolved. The remaining metallic green (JF-1, JF-
1.Cu) crude mixture was dissolved in NH4Cl saturated water-methanol mixture (90:1) and extracted 
using chloroform/ethanol mixtures until the aqueous layer was mostly decolored. The solvents were 
removed under reduced pressure and the crude mixture was redissolved in NH4Cl saturated water-
methanol mixture (90:1) and extracted with chloroform/ethanol. After evaporation of the solvent, the 
reaction mixture was dissolved in toluene and filtered from the ammonium chloride. A further 
purification by DOWEX 50 ion exchange resin (MeOH) and BIO-Beads® SX-1 size-exclusion (200–
400 mesh) using toluene as solvent, microfiltration and precipitation from toluene using n-hexane as 
antisolvent yielded the doubly charged compounds. The analytical purity was determined by NMR. 
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5-Iodo-Triethylammonium-pentane-iodide: The compound was prepared adapting a literature 
procedure for similar compounds (Sebastiano et al., 2001). A solution of acetone (100 mL), 1,5-
diiodopentane (16.2 g, 0.05 mol, 7.44 mL) and triethylamine (5.06 g, 0.05 mol, 7.0 mL) was vigorously 
stirred at 20 °C for 24 h. The amount of the solvent was reduced to 25 mL and the solution was filtered 
from the precipitate. Addition of diethylether to the mother liquor precipitated 5-iodo-
triethylammonium-pentane-iodide as pale yellow solid. Yield: 3.2 g, 15%. 1H NMR (400 MHz, CDCl3) 
δ/ppm: 1.39 (t, 9H, J = 6.2 Hz, NCH3), 1.55 (quint, 2H, J = 7.2 Hz, CH2), 1.75–1.87 (m, 2H, CH2), 1.93 
(quint, 2H, J = 7.1 Hz, CH2), 3.22–3.28 (m, 2H, ICH2), 3.30–3.37 (m, 2H, NCH2), 3.50 (quint, 6H, J = 7.2 
Hz, CH2). 13C NMR (120 MHz, DMSO-d6) δ/ppm: 6.9 (ICH2), 8.4 (CH3), 21.3, 27.3, 32.3 (CH2), 53.8, 57.6 
(NCH2); m/z (HRMS, MICRO-TOF): 298.1018 (C11H25 IN, [M]+, requires 298.1026). 
 
Double charged porphyrin free base JF-1: The 
reaction of porphyrin 16 (57 mg, 0.046 mmol) with 1-iodo-
5-triethylammonium-pentane (500 mg, 1.2 mmol) in 2-
pentanone (4 mL) yielded JF-1. Yield: 48 mg, 75%. 1H 
NMR (500 MHz, DMSO-d6) δ/ppm: –1.60 (br. s, 2H, NH); 
0.86–0.93 (m, 6H; CH3), 1.17–1.23 (m, 9H; CH3), 1.25–1.43 
(m, 22H; CH2), 1.56–1.66 (m, 4H; CH2), 1.66–1.75 (m, 2H, 
CH2), 2.05–2.14 (m, 2H, CH2), 3.12–3.21 (m, 8H; NCH2, 
OCH3), 3.26 (q, 6H, J = 7.2 Hz, NCH2), 3.35–3.44 (m, 8H; NCH2, OCH2), 3.48–3.52 (m, 4H, OCH2), 3.55–
3.58 (m, 4H, OCH2), 3.63–3.67 (m, 4H, OCH2), 3.83–3.90 (m, 4H, OCH2), 4.32–4.41 (m, 4H, OCH2), 4.72 
(t, 2H, J = 6.8 Hz, NCH2), 6.87 (d, 2H, J = 8.7 Hz, CH), 7.48–7.53 (m, 2H, CH), 7.76–7.84 (m, 6H, CH), 
7.92 (d, 2H, J = 8.7 Hz, CH), 8.82 (d, 2H, J = 4.5 Hz, CH), 8.88–8.93 (m, 4H, CH), 9.30 (d, 2H, J = 6.3 Hz, 
CH), 9.71 (d, 2H, J = 4.5 Hz, CH), 9.83 (d, 2H, J = 4.5 Hz, CH). 13C NMR (125 MHz, DMSO-d6) δ/ppm: 
7.2, 14.0 (CH3), 20.5, 22.1, 22.3, 26.4, 26.8, 28.7, 28.9, 30.1, 31.2 (CH2), 50.1, 52.0, 55.7 (NCH2), 58.0 
(OCH3), 60.1 (NCH2), 67.6, 69.1, 69.6, 69.8, 70.0, 71.2 (OCH2), 90.2, 93.4, 94.6, 102.9, 105.5, 106.1, 
107.0, 111.6, 114.9, 120.7, 122.8, 127.2, 128.3, 129.1, 133.5, 139.1, 141.4, 144.6, 148.8, 157.2 (C≡C, 
CHAr, CAr). m/z (MALDI-TOF): 1431.53 (C88H114ClN7O8, [M-HCl]+, requires 1432.84, 100%). m/z 
(HRMS, MICRO-TOF): 698.9380 (C88H115N7O8, [M]2+, requires 698.9398). UV-Vis (DMF, 25 °C) 𝜆max 
(log ε): 448 (5.03); 642 (4.54); 727 (4.67). 
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Figure S9. 1H-NMR spectrum of JF-1 (d6-DMSO, 500 MHz), related to Figure 1.  
 
Double charged copper porphyrin JF-1.Cu: 
The reaction on octyl version of 16.Cu (66 mg, 
0.051 mmol) (synthesized by inserting copper in 
16) with 1-iodo-5-triethylammonium-pentane (514 
mg, 1.2 mmol) in 2-pentanone (4 mL) gave JF-
1.Cu. Yield: 61 mg, 78%. m/z (MALDI-TOF): 
1494.37 (C88H112ClCuN7O8, [M-HCl]+, requires 
1494.76, 100%); m/z (HRMS, MICRO-TOF): 
729.3995 (C88H113CuN7O8, [M]2+, requires 
729.3968). UV-Vis (DMF, 25 °C) 𝜆max (log ε): 449 nm (4.97); 686 nm (4.65). 
 
Porphyrin JF-2: To a solution of the 
corresponding porphyrin 16 (52 mg, 42.4 µmol) in 
acetophenone (2 mL) was added an excess of 1,4-
butane sultone (1.2 mL, 11.7 mmol) and the 
resulting solution was vigorously stirred at 110–
130 °C for approx. 5 h under Ar atmosphere with 
regular TLC monitoring (SiO2: chloroform:MeOH; 
20:1). After the starting material was almost 
consumed, the reaction was quenched by 
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 evaporating the solvents. The slurry crude reaction mixture of JF-2 was directly purified by BIO-Beads® 
S-X1 size-exclusion (200–400 mesh) using toluene as solvent. Microfiltration and precipitation of the 
evaporated prod from toluene using n-hexane as bad solvent yielded the charged compounds. Yield: 
48 mg (83%). 1H NMR (500 MHz, DMSO-d6) δ/ppm: –1.85 (br. s, 2H, NH); 0.85–0.93 (m, 6H; CH3), 1.21–
1.37 (m, 20H; CH2), 1.51–1.60 (m, 4H; CH2), 1.68 (quint, 2H, J = 7.6 Hz, CH2), 2.11 (quint, 2H, J = 7.6 Hz, 
CH2), 2.55 (t, 2H, J = 7.6 Hz, SO3CH2), 3.16 (s, 6H; OCH3), 3.30–3.39 (m, 8H; NCH2, OCH2), 3.48–3.52 (m, 
4H, OCH2), 3.55–3.59 (m, 4H, OCH2), 3.63–3.67 (m, 4H, OCH2), 3.85–3.89 (m, 4H, OCH2), 4.32–4.40 (m, 
4H, OCH2), 4.64 (t, 2H, J = 6.8 Hz, NCH2), 6.75 (d, 2H, J = 8.4 Hz, CH), 7.48–7.53 (m, 2H, CH), 7.69–7.84 
(m, 8H, CH), 8.59 (d, 2H, J = 5.4 Hz, CH), 8.71–8.80 (m, 4H, CH), 9.19 (d, 2H, J = 6.4 Hz, CH), 9.49 (br s, 
4H, CH). 13C NMR (125 MHz, DMSO-d6) δ/ppm: 14.0 (CH3), 21.7, 22.1, 26.4, 26.8, 28.7, 28.9, 30.0, 31.3 
(CH2), 50.1, 50.4 (SO3CH2, NCH2), 58.0 (OCH3), 60.2 (NCH2), 67.6, 69.1, 69.6, 69.8, 70.0, 71.2 (OCH2), 
90.0, 93.1, 94.4, 102.4, 105.1, 105.7, 107.0, 111.4, 114.8, 120.7, 122.6, 127.3, 128.2, 128.7, 133.3, 
138.6, 141.4, 144.4, 148.6, 157.2 (C≡C, CHAr, CAr). m/z (MALDI-TOF): 1362.90 (C81H98N6O11S, [M]+, 
requires 1362.70, 100%); m/z (HRMS, MICRO-TOF): 1385.6862 (C81H98N6NaO11S, [M+Na]+, requires 
1385.6906). UV-Vis (DMF, 25 °C) 𝜆max (log ε): 446 (5.05); 640 (4.58); 726 (4.72). 
 
Figure S10. 1H NMR spectrum of JF-2 (d6-DMSO, 500 MHz, DOSY experiment), related to Figure 1. 
  
 3.2  Synthesis of AK-1 and AK-1.Cu 
 
 
 
 
 
 
Scheme S2. Synthetic procedure for AK-1, Related to Figure 1. 
 
Compound 18: Compound 18 was synthesized according to the literature 
procedure (Yi et al., 2016). Briefly, N,N,N′,N′-tetramethyl-1,3-propanediamine 17 
(5.0 g) was dissolved in diethyl ether (100 mL) and stirred. Methyl iodide (2.38 mL, 
1 eq.) was added dropwise and the reaction mixture was stirred for 20 min until white precipitate 
formed. The white precipitate was washed with water (100 mL) three times and dried under high 
vacuum to yield 18 as a white amorphous powder. Yield: 1.45 g, 14%. 1H NMR (400 MHz, D2O) 
δ/ppm: 3.31 (m, 2H), 3.12 (s, 9H), 2.41 (m, 2H), 2.21 (s, 6H), 1.96 (m, 2H). 13C NMR (100 MHz, D2O) 
δ/ppm: 64.7, 54.6, 52.8, 43.6, 20.1. m/z (ESI+) 145.2, 146.2 (C8H21N2+ M+ requires 145.2, C8H22N2+ 
[M+H]+ requires 146.2).  
 
Compound 19: 3-(Dimethylamino)-N,N,N-trimethylpropan-1-aminium 
iodide 18 (600 mg, 2.2 mmol) was dissolved in acetonitrile (5 mL) and 
stirred followed by addition of 1,3-diiodpropane (2.7 mL, 22.0 mmol, 10 
eq.). The reaction mixture was refluxed for 24 h. The solvent was evaporated under reduced pressure to 
form a yellow solid powder, which was washed with acetone to give 19 as a white powder. Yield: 1.2 
g, 93%. 1H NMR (400 MHz, D2O) δ/ppm: 3.52 (m, 2H), 3.45 (m, 4H), 3.29 (t, 2H, 3J = 6.4 Hz), 3.21 (s, 
9H), 3.18 (s, 6H), 2.36 (m, 4H). 13C NMR (100 MHz, D2O) δ/ppm: 62.3, 64.9, 60.0, 53.2, 51.0, 25.5, 17.0, 
–0.3. m/z  (ESI+) 441.0 (C11H27I2N2+, M+ requires 441.0). 
 
Compound 3: N1-(3-Iodopropyl)-N1,N1,N3,N3,N3-pentamethylpropane-
1,3-bis(aminium)-diiodide 19 (1.0 g, 1.7 mmol) was dissolved in water just 
below saturation concentration. Ammonium hexafluorophosphate (900 
mg, 5.1 mmol, 3 eq.) solution in water was added dropwise and stirred at RT for 15 min to form 
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 precipitates. The precipitate was washed with water (100 mL) and dried under high vacuum to give 
product 3 as white solid. 1H NMR (400 MHz, d6-DMSO) δ/ppm: 3.38 (m, 2H), 3.31 (m, 4H), 3.24 (t, 2H, 
3J = 6.8 Hz), 3.11 (s, 9H), 3.09 (s, 6H), 2.22 (m, 4H). 13C NMR (100 MHz, d6−DMSO) δ/ppm: 63.9, 61.8, 
59.6, 52.6, 50.6, 25.8, 16.8, 1.5. m/z  (ESI+) 459.0, 460.0.0 (C11H27F6IPN2+ M+ requires 459.0, 
C11H28F6IPN2+ [M+H]+ requires 460.0). 
 
Compound 20: Compound 20 was synthesized as per l iterature 
procedure (Reeve et al., 2009). n-Butyl lithium (11.2 mL, 2.5 M solution in 
hexane) was added dropwise to a stirred solution of trihexylsilyl acetylene 9 
(6.6 g, 21.3 mmol), in dry THF (18 mL) at 0 °C. The mixture was stirred for 15 min at 0 ºC and then 
another 15 min at RT. The reaction mixture was transferred via cannula to a stirred solution of DMF (5 
mL, mmol) in dry THF (18 mL) and stirred for 2 h at −80 ºC. The reaction mixture was quenched with 
HCl (10% v/v, 50 mL), washed with H2O and extracted with Et2O. The solution was dried over Na2SO4 
and concentrated to give 20 as yellow oil. Yield: 6.71 g, 93.5%. 1H NMR (400 MHz, CDCl3) δ/ppm: 
9.17 (s, 1 H, CHO), 1.45–1.20 (m, 24 H, 2-5 hexyl-H), 0.89 (t, 9 H, 3J = 6.7 Hz, 6 hexyl-H), 0.68 (m, 6 H, 1-
hexyl-H). 13C NMR (100 MHz, CDCl3) δ/ppm: 175.9, 103.6, 102.5, 33.1, 31.5, 23.8, 22.7, 14.2, 12.6. 
 
Porphyrin 21: Porphyrin 21 was prepared according to an 
adapted literature procedure (Anderson, 1992). 
Dipyrromethane (1.55 g, 10.60 mmol) was dried in vacuo for 
1 h before addition of dry CH2Cl2 (600 mL) and trihexylsilyl 
propynal (3.7 g, 11.00 mmol). The solution was freeze-
pump-thaw-degassed and BF3.OEt2 (450 μL, 3.64 mmol) was added and the mixture was stirred at room 
temperature for 45 min in the dark. After this time, DDQ (3.43 g, 15.11 mmol) was added and the 
mixture was stirred under air for 10 min. The crude mixture was passed through a large silica plug 
(CH2Cl2) and further purified by flash chromatography on silica (4:1 40–60 °C petrol ether: CH2Cl2). 
Fractions were evaporated to give 21 as a purple oil. Yield: 1.65 g, 16.8%. 1H NMR (400 MHz, CDCl3 
with 1% C5D5N) δ/ppm: 10.09 (s, 2 H, meso-H), 9.67 (d, 4 H, 3J = 4.5 Hz, β- H), 9.28 (d, 4 H, 3J = 4.5 Hz, 
β- H), 1.86–1.74 (m, 12 H, hexyl-H), 1.64–1.54 (m, 12 H, hexyl-H), 1.50–1.35 (m, 24 H, hexyl-H), 1.10-1.02 
(m, 12 H, hexyl-H), 0.93 (t, 18 H, 3J = 7.06 Hz, hexyl-H). 
 
Porphyrin 22: Porphyrin 22 was prepared according to literature 
procedure (Reeve et al., 2009). Amylene stabilized CHCl3 was 
passed through alumina and then mixed with 1% of dry EtOH. 
Porphyrin 21 (500 mg, 0.54 mmol) was dissolved in the CHCl3 (25 
mL). The solution was put under Ar before n-Bu4NF (0.54 mL, 1 M in 
THF,) was added. The reaction was carefully monitored by TLC (PET ether 40- 60 °C : EtOAc 10 : 1) - 
spotted every 10 min. When starting material and monodeprotected product appeared roughly equal in 
intensity, the reaction was quenched by pouring directly onto a silica plug in CH2Cl2. Crude reaction 
mixture was purified by flash chromatography on SiO2 (PET ether 40–60 °C : EtOAc 20 : 1 : 1). Fractions 
containing monodeprotected porphyrin 22 were evaporated to dryness to give a purple glass. Yield: 
145 mg, 42%. 1H NMR (400 MHz, CDCl3) δ/ppm: 9.83 (s, 2H, meso-H), 9.57 (d, 2H, 3J = 4.3 Hz, β-H), 
9.52 (m, 2H, β-H), 9.13 (m, 4H, β-H), 4.21 (s, 1H, acetylene-H), 1.92–1.82 (m, 6H, hexyl-H), 1.70–1.60 (m, 
6H, hexyl-H), 1.56–1.40 (m, 12H, hexyl-H), 1.16–1.06 (m, 6H, hexyl-H), 0.98 (t, 9 H, 3J = 7.0 Hz, hexyl-H), 
−3.65 (br s, 2H, -NH). 
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Compound 23: Compound 23 was prepared as per literature procedure (Mohr et al., 
1997). 4-Iodoaniline (5.00 g, 22.8 mmol) was mixed with butyl iodide (10 mL, 88.0 
mmol) with Na2CO3 (8.00 g) in DMF (13 mL). The mixture was degassed and then 
stirred under Ar for 18 h at 100 ºC. The crude mixture was diluted with toluene, 
washed with water. The crude reaction was again mixed with chloroform and washed 
with water (3 × 200 mL) and dried over Na2SO4. The solvent was evaporated, and the 
crude material was purified by column chromatography on silica (9:1 40–60 °C petrol 
ether:CH2Cl2). Yield: 7.6 g, 100%. 1H NMR (400 MHz, CDCl3) δ/ppm: 7.41 (d, 2 H, 3J = 9.09 Hz, Ar-H), 
6.41 (d, 2 H, 3J = 9.17 Hz, Ar-H), 3.22 (t, 4 H, 3J = 7.53 Hz), 1.53 (m, 4 H), 1.33 (m, 4H), 0.94 (t, 6 H, 3J = 
7.34 Hz). 13C NMR (100 MHz, CDCl3) δ/ppm: 147.7, 137.7, 114.1, 100.1, 50.8, 29.3, 20.4, 14.1. m/z  
(ESI+) 332.0, 333.0 (C14H22IN, M+H requires 332.0, M+2H requires 333.0). 
 
Porphyrin 24: 5-Ethynyl-15-[(trihexylsilyl)ethynyl]porphyrin 
22, (140 mg, 0.218 mmol), Pd2(dba)3 (22 mg, 0.021 mmol), 
PPh3 (25 mg, 0.095 mmol), and CuI (5 mg, 0.026 mmol) were 
transferred and dried in a Schlenk tube in vacuo for 1 h. DIPA 
(8 mL) and toluene (8 mL) were added and the reaction 
mixture thoroughly freeze-pump-thaw degassed (3 cycles). 4-
Iodo-N,N-dibutylaniline 23 (721 mg, 2.18 mmol) was added 
to the reaction mixture and the mixture was stirred at 50 °C for 1 h under Ar. Progress of the reaction 
was monitored by TLC (PET ether 40–60 °C : EtOAc 10 : 1). Upon completion, the mixture was passed 
through a silica plug (CH2Cl2), concentrated and purified by flash chromatography on SiO2 (PET ether 
40–60 °C : CH2Cl2 20 : 1 : 1 to 10 : 1 : 1 to 5: 1 : 1). Porphyrin 24 was obtained as a green glass. Yield: 
172 mg, 93%. 1H NMR (400 MHz, CDCl3) δ/ppm: 9.91 (s, 2H, meso-H), 9.65 (m, 2H, β-H), 9.58 (d, 2H, 3J 
= 4.3 Hz, β-H), 9.18 (m, 4H, β-H), 7.92 (d, 2H, 3J = 8.6 Hz, aniline-H), 6.84 (d, 2H, 3J = 8.6 Hz, aniline-H), 
3.42 (t, 4H, 3J = 7.8 Hz ,butyl-H), 1.90–1.80 (m, 6H, hexyl-H), 1.77–1.38 (m, 26H, butyl-H, hexyl-H), 1.13–
1.03 (m, 12H, butyl-H, hexyl-H), 0.97 (t, 9H, 3J = 6.8 Hz, hexyl-H), −2.83 (br s, 2H, -NH). m/z  (MALDI-
ToF): 843.57, 844.56, 845.56 (C56H73N5Si, M requires 843.56, M+H requires 844.56, M+2H requires 
845.56). 
 
Porphyrin 25: Intermediate porphyrin 25 was prepared as follows: 
TBAF (1.0 M in THF, 0.402 mL, 0.402 mmol) was added to a solution 
of 24 (170 mg, 0.201 mmol) in CH2Cl2 (30 mL) and stirred for 20 min 
at RT. The reaction mixture was passed through a silica plug 
(CH2Cl2) and evaporated to dryness to give 25. Yield:112 mg, 
100%. The crude product mixture contained trihexylsilane as 
byproduct. The crude product mixture was taken forward for 
Sonogashira coupling without any further purification because of high reactivity of the product. 1H 
NMR (400 MHz, CDCl3) δ/ppm: 10.01 (s, 2H, meso-H), 9.72 (d, 2H, 3J = 4.5 Hz, β-H), 9.63 (d, 2H, 3J = 
4.5 Hz, β-H), 9.25 (m, 4H, β-H), 7.91 (d, 2H, 3J = 8.8 Hz, aniline-H), 6.83 (d, 2H, 3J = 8.8 Hz, aniline-H), 
4.20 (s, 1H, acetylene-H), 3.43 (m, 4H, butyl-H), 1.75–1.65 (m, 4H, butyl-H), 1.52–1.42 (m, 4H, butyl-H), 
1.05 (t, 6H, 3J = 7.4 Hz, butyl-H), −2.61 (br s, 2H, -NH). 
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Porphyrin 1: N,N-Dibutyl-4-[(15-ethynylporphyrin-5-
yl)ethynyl]aniline 25 (112 mg, 0.201 mmol) was mixed with 
Pd2(dba)3 (18 mg, 20.1 μmol), PPh3 (21 mg, 80.0 μmol), CuI (4 
mg, 21.0 μmol) and 4-iodopyridine (400 mg, 2.014 mmol) 
were dried in vacuo for 1 h before DIPA (9 mL) and toluene (9 
mL) were added and the mixture freeze-pump-thaw degassed. 
The mixture stirred at 40°C for 3 h under Ar. Upon 
completion, the mixture was passed through a silica plug (CH2Cl2 with 5% MeOH) then purified by flash 
chromatography (CH2Cl2:THF 5:1 to 3:1) and the fractions were evaporated to dryness. The product 
mixture was recrystallized (MeOH layered over CHCl3) to give 1 as a green solid. Yield: 115 mg, 
90%. 1H NMR (400 MHz, CDCl3) δ/ppm: 9.89 (s, 2H, meso-H), 9.66 (m, 2H, β-H), 9.52 (m, 2H, β-H), 9.16 
(m, 4H, β-H), 8.84 (m, 2H, pyridine-H), 7.91 (d, 2H, 3J = 8.8 Hz, aniline-H), 7.88 (m, 2H, pyridine-H), 6.84 
(d, 2H, 3J = 8.8 Hz, aniline-H), 3.44 (m, 4H, butyl-H), 1.77–1.67 (m, 4H, butyl-H), 1.53–1.43 (m, 4H, butyl-
H), 1.05 (t, 6H, 3J = 7.4 Hz, butyl-H), −2.61 (br s, 2H, -NH). m/z  (MALDI-ToF): 638.89, 639.84, 630.79 
(C43H38N6, M requires 638.31, M+H requires 639.31, M+2H requires 640.31). UV-Vis (DMF, 25 ºC) 𝜆max 
(log ε): 692 nm (4.36), 614 nm (4.41), 422 nm (4.89).  
 
Porphyrin AK-1: Porphyrin 1 (15 mg, 22.5 
µmol) was mixed with N1-(3-iodopropyl)-
N1,N1,N3,N3,N3-pentamethylpropane-1,3-
diaminium-di(hexafluorophosphate) 3 (600 
mg, 1 mmol, 45 eq.) and dried under high 
vacuum at 50 °C for 4 h. Dry 
dimethylacetamide (1.5 mL) was added to the mixture and the reaction mixture was stirred at 115 °C for 
6 h in inert atmosphere. TLC (20% THF in DCM) confirmed the consumption of starting material. Solvent 
was evaporated from crude mixture which was then purified by size-exclusion column chromatography 
(SX-1 beads in DMF). The second band (product) was passed through a Dowex 1X8 chloride form ion-
exchange chromatography column. The reaction mixture was then sequentially washed with water (3 × 
30 mL), MeOH (3 × 30 mL) and diethyl ether (1 × 30 mL). The process of ion-exchange and washing was 
repeated. In the end, the reaction mixture was again passed through the size-exclusion column 
chromatography (SX-1 beads in DMF). The solvent was evaporated under reduced pressure to yield the 
product AK-1 as green solid. Yield: 11 mg, 50%. 1H NMR (500 MHz, d6−DMSO at 50 °C) δ/ppm: 
10.46 (s, 2H, meso-H), 9.90 (d, 2H, 3J = 4.5 Hz, β-H), 9.78 (d, 2H, 3J = 4.5 Hz, β-H), 9.65 (d, 2H, 3J = 4.5 
Hz, β-H), 9.56 (d, 2H, 3J = 4.5 Hz, β-H), 9.28 (d, 2H, 3J = 6.1 Hz, pyridine-H), 9.00 (d, 2H, 3J = 6.1 Hz, 
pyridine-H), 7.99 (d, 2H, 3J = 8.4 Hz, aniline -H), 6.92 (d, 2H, 3J = 8.4 Hz, aniline-H), 4.77 (t, 2H, 3J = 4.4 
Hz, CH2) 3.52 (m, 2H, CH2), 3.35 (t, 4H, 3J = 7.6 Hz, butyl-H), 3.36 (m, 4H, 2CH2), 3.15 (m, 15 H, methyl-
H), 2.64–2.54 (m, 2H, CH2), 2.28–2.18 (m, 2H, CH2), 1.68–1.58 (m, 4H, butyl-H), 1.49–1.39 (m, 4H, butyl-
H), 1.01 (t, 6H, 3J = 7.4 Hz, butyl-H). m/z  (MALDI-ToF): 1114.96 (C54H65N8F12P2, M requires 1115.46). 
UV-Vis (DMF, 25 °C) 𝜆max (log ε): 709 nm (4.37), 631 nm (4.24), 440 nm (4.67). Quantum yield ϕf 
(DMF, 25 °C): 0.0033. 
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Figure S11. 1H-NMR spectrum of AK-1 (d6−DMSO, 50 °C, 500 MHz, DOSY experiment), related to 
Figure 1. 
 
 
Porphyrin AK-1.Cu: Porphyrin AK-1 (7 mg, 
7.5 µmol) was dissolved in DMF (1 mL). Excess 
of copper(II) acetate monohydrate (30 mg) was 
dissolved in MeOH (1 mL) and mixed with the 
DMF containing porphyrin. The mixture was 
heated for 8 h at 50 °C after which the solvent 
was evaporated under reduced pressure. The formation of the product was confirmed by UV-Vis 
spectroscopy. The crude mixture was re-dissolved in DMF (0.5 mL) and passed through a small plug of 
SX-1 beads. The solvent was evaporated, and the porphyrin was washed with methanol and distilled 
water two times each. The purified product was dried under high vacuum overnight. Yield: 5.0 mg, 
67%. m/z  (MALDI-ToF): 1176.27 (C54H63N8F12P2Cu, M requires 1176.37). UV-Vis (DMF, 25 °C) 𝜆max 
(log ε): 668 nm (4.51), 441 nm (4.74). 
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 3.3 Synthesis of IG-1  
 
 
 
 
 
 
 
Scheme S3. Synthetic procedure for IG-1, related to Figure 1. 
 
Compounds 26, 27, 28, 29, and 30 were synthesized according to the literature procedures 
(Dominguez et al., 1961; Newkome et al., 1991; Selve et al., 1991; Snow and Foos, 2003). 
 
Compound 32: Iodoisophthalic acid 31 (500 mg, 1.7 mmol) was refluxed in SOCl2 
(15 mL, 200 mmol) for 16 h. Excess of thionyl chloride was removed by distillation 
and the resulting acid chloride was dried under high vacuum. The 3-iodoisophthalic 
acid chloride (563 mg, 1 eq.) was not characterized and instead it was dissolved in 
dry THF (3 mL) and used immediately in the following peptide coupling step. The 
solution of Behera’s amine 30 (1.56 g, 2.2 eq.) with Et3N (277 μL) was also prepared 
in dry THF (3 mL) and added dropwise to the solution of bis-acid chloride. Reaction 
mixture was left to stir overnight at room temperature. The reaction mixture was 
concentrated to form a viscous yellow crude oil. Purification was carried out by flash 
chromatography on SiO2 (PET ether 40–60 °C:EtOAc 10:1 to 5:1 to neat EtOAc). The fraction containing 
the product was concentrated and dried under high vacuum overnight to afford 32 as a white 
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 crystalline powder. Yield: 702 mg, 37.5%. 1H NMR (400 MHz, CDCl3) δ/ppm: 8.30 (d, 2H, J = 1.6 Hz, 
Ar-H), 8.28 (t, 1H, J = 1.4 Hz, Ar-H), 7.31 (s, 2H, Amide-H), 2.30 (t, 12H, J = 7.4 Hz, CH2) 2.12 (t, 12H, J 
= 7.4 Hz, CH2), 1.44 (s, 54H, t-Bu).  
 
Compound 33: Compound 32 (200 mg, 184 μmol, 1 eq.) was dissolved in 98% 
formic acid (8.1 mL) and left stirring at room temperature for 24 h. On the next day, 
the solution was concentrated and toluene (8 mL) was added to help azeotropically 
remove the residual formic acid. On evaporation, the product 33 was obtained as a 
white powder. Yield: 138 mg. 1H NMR (400 MHz, DMSO-d6) δ/ppm: 12.24 (br. s, 
6H, Acid-H), 8.26 (m, 2H, Ar-H), 8.15 (m, 1H, Ar-H), 7.75 (br. s, 2H, Amide-H), 2.17 (t, 
12H, J = 7.6 Hz, CH2), 1.98 (t, 12H, J = 8.8 Hz, CH2).  
 
Compound 4: 3-Iodoisophthalic acid 33 (50 mg, 67 µmol, 1 eq.) was dissolved in 
dry DMF (0.2 mL) and cooled in an ice bath to 0 °C. In parallel compound 28 (247 
mg, 800 µmol, 12 eq.) was dissolved in dry DMF (0.2 mL) and also cooled to 0 °C. 
To each cooled solution DIPEA (0.070 mL, 800 µmol, 12 eq.) was added. Next, to 
the solution of compound 33, COMU (El-Faham and Albericio, 2010) coupling 
reagent (218 mg, 800 µmol, 12 eq.) was added and stirred for 1 min before the 
solution of amine was added dropwise. Combined solutions were stirred for 1 h at 
0 °C and an additional 2 h at room temperature. Crude reaction mixture was 
worked up by diluting with EtOAc (20 mL) and a following washing with HCl (1.0 
M, 2 × 5 mL), NaHCO3 (1.0 M, 2 × 5 mL) and saturated NaCl (2 × 5 mL). The aqueous phase was 
additionally washed with DCM (4 × 200 mL) (until no more UV active compound partitioned into DCM) 
which was then combined with the organic phase. The product was purified by size-exclusion 
chromatography (CHCl3) to obtain 4 as an oil. Yield: 131 mg, 78 %. 1H NMR (400 MHz, CDCl3) δ/ppm: 
8.76 (br s, 2H, amide-NH), 8.40 (s, 1H, Ar-H), 8.30 (s, 2H, Ar-H), 3.63–3.47 (br m, 74H, TEG-CH2), 3.35 (s, 
9H, TEG-OCH3), 3.33 (s, 9H, TEG-OCH3), 2.46 (t, 6H, J = 6.2 Hz, CH2), 2.15 (t, 6H, J = 6.2 Hz, CH2).  
 
Porphyrin IG-1.Zn: Trihexylsilylacetylene,15-ethynyl 
porphyrin 2 (21 mg, 20.6 µmol, 1.5 eq.) and Pd(PPh3)4 (4.16 
mg, 3.6 µmol, 0.2 eq.), CuI (0.7 mg, 3.6 µmol, 0.2 eq.) and 
compound 4 (30 mg, 12 µmol, 1 eq.) were transferred and 
dried in a Schlenk tube in vacuo for 1 h. THF (0.5 mL) and 
DIPA (0.5 mL) was added and the reaction mixture thoroughly 
freeze-pump-thaw degassed (4 cycles). Bu4NF (0.18 mL, 180 
µmol, 1 M in THF, 15 eq.) was added to the reaction mixture and the mixture was freeze-pump-thaw 
degassed again (another 2 cycles) then brought to 50 °C and stirred for 3 h under N2. Progress of the 
reaction was monitored by TLC (PET ether 40–60 °C:EtOAc:Py 10:1:1). On completion the mixture was 
passed through a silica plug (PET ether 40–60 °C:EtOAc 3:1), concentrated and purified by flash 
chromatography on SiO2 (PET ether 40–60 °C: CH2Cl2:Py 20:1:1 to 10:1:1 to pure CH2Cl2). Product IG-
1.Zn was obtained as a green solid. Yield: 30 mg, 80%. 1H NMR (400 MHz, CDCl3) δ/ppm: 9.97 (s, 2H, 
meso-CH), 9.78 (m, 4H, β-CH), 9.24 (m, 4H, β-CH), 8.80 (br s, 2H, amide-NH), 8.58 (s, 2H, Ar-H), 8.53 (s, 
1H, Ar-H), 7.84 (d, 2H, J = 8.8 Hz, Araniline-H), 6.75 (d, 2H, J = 8.9 Hz, Araniline-H), 3.61–3.23 (s, 148H, 
TEG(CH3)-H), 3.20 (s, 18H, TEG(CH3)-H), 3.18 (s, 18H, TEG(CH3)-H), 2.50 (t, 12H, J = 6.8 Hz, CH2), 2.22 
(t, 12H, J = 6.4 Hz, CH2), 1.63 (m, 6H, octyl-CH2), 1.38–1.21 (m, 22H, octyl-CH2), 0.85 (t, 6H, octyl-CH3). 
m/z (MALDI-TOF): 3129.85 ([M+Na]+ 100%, C158H257N13O44ZnNa+ requires 3129.75). 
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Porphyrin IG-1: Compound IG-1.Zn (5.0 mg, 1.6 µmol, 1 
eq.) was dissolved in CHCl3 (0.5 mg) in a dry round bottom 
flask. TFA (12.5 µL, 100 eq.) was added at once to the solution 
of the porphyrin. Reaction was allowed to proceed for 15 min. 
On completion, the reaction was stopped by pouring the 
reaction mixture into a flask with large volume of CHCl3 (50 
mL) and washing the resultant diluted solution with saturated 
solution of NaHCO3 until basic pH is reached. Organic phase was separated and dried with MgSO4, 
then filtered and concentrated. Product was obtained as a dark green solid. Yield: 3.5 mg, 70 %. 1H 
NMR (400 MHz, CDCl3) δ/ppm: 10.05 (s, 2H, meso-CH), 9.71 (m, 4H, β-CH), 9.27 (d, 2H, J = 4.6 Hz, β-
CH), 9.24 (d, 2H, J = 4.5 Hz, β-CH), 8.86 (br s, 2H, amide-NH), 8.61 (s, 2H, Ar-H), 8.58 (s, 1H, Ar-H), 7.84 
(d, 2H, J = 8.4 Hz, Araniline-H), 6.75 (d, 2H, J = 8.9 Hz, Araniline-H), 3.6–3.23 (m, 160 H, TEG(CH2-CH3)), 2.51 
(t, 12H, J = 6.6 Hz, CH2), 2.22 (t, 12H, J = 6.5 Hz, CH2), 1.64 (m, 6H, octyl-CH2), 1.38–1.21 (m, 22H, octyl-
CH2), 0.86 (t, 6H, octyl-CH3), –2.28 (s, 4H, NH-ring). m/z (MALDI-TOF): 3066.78 ([C158H259N13O44Na+ 
[M+Na]+ requires 3066.84). UV-Vis (DMF, 25 °C) 𝜆max (log ε): 430 nm (4.83); 614 nm (4.34); 692 nm 
(4.30). 
 
 
Figure S12: 1H-NMR spectrum of IG-1 (CDCl3, 400 MHz), related to Figure 1. 
 
N
NH N
HN
(C8H17)2N
HN
HN
O
O
N(TEG)2
N(TEG)2
O O
N(TEG)2
O
N(TEG)2
O
N(TEG)2
ON(TEG)2
O
 3.4 Synthesis of JW-1  
 
 
 
 
 
 
Scheme 4. Synthetic procedure for JW-1, related to Figure 1. 
 
Compounds 35, 36, and 37 were synthesized as per the protocol followed during synthesizing 
intermediates for IG-1. 
 
Compound 38: Iodoisophthalic acid 31 (0.50 g, 1.7 mmol) was refluxed in SOCl2 (15.0 mL, 
207 mmol) for 16 h to form 34. SOCl2 was removed under reduced pressure and the 
brown/red oily residue was dried under high vacuum for several hours. The oil was stored 
under N2 and used within 24 h. The oil (81 mg, 0.25 mmol) was dissolved in THF (1.7 mL) and 
added dropwise to a solution of 37 (340 mg, 0.59 mmol) in THF (1.7 mL) and Et3N (83 µL, 
0.59 mmol) at 0 °C. The reaction was stirred at 20 °C for 3 h and then the precipitate was 
filtered, and the solvent was evaporated under reduced pressure. The crude residue was 
dissolved in CH2Cl2, washed with 1.0 M aq. HCl and extracted with CH2Cl2. The organic 
layers were dried over MgSO4 and filtered. Size-exclusion chromatography used to purify the 
product to yield 38. Yield: 0.26 g, 73 %. 1H NMR (400 MHz, d6−DMSO) δ/ppm: 7.74 (d, J 
= 1.2 Hz, 2 H), 7.31 (t, J = 1.2 Hz, 1 H), 3.36–3.72 (m, 96 H), 3.31 (s, 12 H). 13C NMR (100 
MHz, d6−DMSO) δ/ppm: 169.7, 138.8, 136.5, 124.7, 93.6, 71.9, 70.6, 70.5, 70.4, 69.1, 68.6, 59.0, 49.8, 
45.0. m/z  (ESI+) 724.3110 (C60H111IN2O26 (M + 2Na)2+: 724.3127 requires 724.3110). 
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Porphyrin JW-1.Zn: To a pre-dried Schlenk tube were 
added porphyrin 2 (25 mg, 25 µmol), 38 (35 mg, 25 µmol), 
Pd(PPh3)4 (2.9 mg, 2.5 µmol) and CuI (0.5 mg, 3 µmol). 
These were dried under vacuum for 30 mins, then the flask 
purged with N2 to allow addition of THF (1 mL) and DIPA 
(1 mL). The mixture was freeze pump-thaw degassed 3 times, then Bu4NF (1.0 M solution in THF, 0.25 
mL, 0.25 mmol) was added and the reaction heated to 50 °C under N2. After 2 h, the reaction was 
passed through a column of silica, eluting with THF : 1% pyridine then CHCl3 : 10% MeOH : 1% 
pyridine. The crude mixture was concentrated and purified by size-exclusion chromatography (CHCl3) to 
isolate the desired product as a green solid after drying. Yield: 25 mg, 50%. 1H NMR (400 MHz, 
CDCl3) δ/ppm: 10.05 (s, 2 H, meso-H), 9.85 (d, J = 4.3 Hz, 2 H, β-H), 9.78 (d, J = 4.5 Hz, 2 H, β-H), 9.33 
(d, J = 4.5 Hz, 2 H, β-H), 9.31 (d, J = 4.3 Hz, 2 H, β-H), 8.14 (d, J = 1.5 Hz, 2 H, Ar-ortho-H), 7.91 (d, J = 
8.8 Hz, 2 H, aniline-H), 7.52 (t, J = 1.5 Hz, 1 H, Ar-para-H), 6.82 (d, J = 9.1 Hz, 2 H, aniline), 3.10–3.93 
(m, 112 H, HEG, N-CH2-C7H15, O-CH3), 1.29–1.44 (m, 20 H), 0.93 (t, J = 6.3 Hz, 6 H). 13C NMR (125 
MHz, CDCl3 with 1% d5-pyridine) δ/ppm: 170.9, 152.1, 151.8, 149.2, 148.2, 137.7, 133.0, 132.4, 131.8, 
131.4, 130.8, 130.5, 125.0, 124.7, 111.5, 109.6, 107.7, 102.8, 98.4, 97.6, 94.9, 94.2, 91.0, 71.8, 71.8, 
70.6, 70.5, 70.3, 70.2, 70.2, 69.2, 69.0, 59.0, 58.9, 51.1, 49.9, 45.3, 31.8, 29.5, 29.3, 27.3, 27.2, 22.7, 
14.1. MS Calcd for. m/z (MALDI-TOF): 2034.94 (C106H159N7O26Zn [M + Na] requires 2035.05). 
 
Porphyrin JW-1: Porphyrin JW-1.Zn (10 mg, 4.9 µmol) 
was dissolved in CHCl3 (4.4 mL) and the solution was 
stirred. TFA (88 mL, 1.2 mmol) was added and the reaction 
stirred for further 1 h, after which aq. sat. NaHCO3 was 
added (2 mL). The product was washed with water (2 × 5 
mL), extracted with CHCl3 (2 × 5 mL), dried over MgSO4 and concentrated. The product was 
precipitated as a film by addition of 60–80 petrol ether to a CH2Cl2 solution, followed by careful 
evaporation of the CH2Cl2 and addition of pentane, yielding the clean product JW-1. Yield: 8.7 mg, 
90%. 1H NMR (400 MHz, CDCl3) δ/ppm: 10.09 (s, 2 H, meso-H), 9.75 (d, J = 4.4 Hz, 2 H, β-H), 9.69 (d, J 
= 4.7 Hz, 2 H, β-H), 9.32 (d, J = 4.6 Hz, 2 H, β-H), 9.29 (d, J = 4.3 Hz, 2 H, β-H), 8.14 (br s, 2 H, Ar-ortho-
H), 7.91 (d, J = 8.5 Hz, 2 H, aniline-H), 7.56 (s, 1 H, Ar-para-H), 6.82 (d, J = 8.9 Hz, 2 H, aniline-H), 3.26–
3.93 (m, 112 H, HEG, N-CH2-C7H15, O-CH3), 1.68–1.78 (m, 9 H), 1.23–1.42 (m, 33 H), 0.93 (t, J = 6.8 Hz, 
6 H), –2.27 (br. s., 2 H, N-H). 13C NMR (125 MHz, CDCl3) δ/ppm: 169.8, 147.5, 144.1, 136.7, 132.3, 
131.3, 130.6, 129.8, 129.4, 128.8, 124.2, 123.4, 110.5, 107.9, 106.0, 102.1, 99.4, 96.9, 94.4, 91.7, 88.5, 
70.9, 70.8, 70.8, 69.6, 69.5, 69.5, 69.3, 69.3, 69.2, 68.2, 67.9, 58.0, 57.9, 52.4, 50.1, 48.9, 44.3, 30.8, 
28.5, 28.3, 26.3, 26.2, 21.7, 13.1. m/z (MALDI-TOF): 1971.77 (C106H161N7O26Na, (M + Na) 
requires1972.14). UV-Vis (DMF, 25 °C) 𝜆max (log ε): 425 nm (5.01); 615 nm (4.57); 693 nm (4.53). 
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Figure S13. 1H-NMR spectrum of JW-1 (CDCl3, 400 MHz), related to Figure 1. 
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